.RESEARCH STUDY FEATURE.06 August 2024.
A sizable randomized measured trial along with cisgender women highlights the obstacles of fidelity to a day-to-day dental preexposure prophylaxis routine as well as demonstrates that twice-yearly treatment of lenacapavir can sustain successful HIV prevention levels over 6 months.